We are live on ! Find out more

Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
OMER icon
151
Omeros
OMER
$1.37B
$1.37B $18.95 0.84%
MGTX icon
152
MeiraGTx Holdings
MGTX
$1.33B
$1.33B $13.89 0.57%
ORIC icon
153
Oric Pharmaceuticals
ORIC
$1.33B
$1.33B $12.86 0.94%
SPTX
154
Seaport Therapeutics
SPTX
$1.33B
$1.33B $24.86 2.35%
MNKD icon
155
MannKind Corp
MNKD
$1.31B
$1.31B $4.06 2.53%
MLTX icon
156
MoonLake Immunotherapeutics
MLTX
$1.28B
$1.28B $15.01 1.18%
JBIO
157
Jade Biosciences
JBIO
$1.27B
$1.27B $19.90 0.25%
JANX icon
158
Janux Therapeutics
JANX
$1.24B
$1.24B $20.24 2.22%
CRVS icon
159
Corvus Pharmaceuticals
CRVS
$1.21B
$1.21B $14.39 1.77%
GLUE icon
160
Monte Rosa Therapeutics
GLUE
$1.18B
$1.18B $13.84 3.76%
KURA icon
161
Kura Oncology
KURA
$1.18B
$1.18B $13.25 0.76%
ATTO
162
Attovia Therapeutics
ATTO
$1.17B
$1.17B $25.55 5.58%
SANA icon
163
Sana Biotechnology
SANA
$1.15B
$1.15B $3.85 1.79%
APMD
164
Apnimed Inc
APMD
$1.14B
$1.14B $27.45 1.29%
IVA
165
Inventiva
IVA
$1.13B
$1.13B $4.78 1.24%
SVRA icon
166
Savara
SVRA
$1.1B
$1.1B $5.37 0%
SLDB icon
167
Solid Biosciences
SLDB
$1.1B
$1.1B $10.25 1.63%
MRVI icon
168
Maravai LifeSciences
MRVI
$1.09B
$1.09B $7.32 0.68%
OBX
169
Obsidian Therapeutics
OBX
$1.04B
$1.04B $16.82 1.58%
FTH
170
Faeth Therapeutics
FTH
$1.03B
$1.03B $40.05 2.69%
AVTX icon
171
Avalo Therapeutics
AVTX
$1.03B
$1.03B $19.23 1.21%
ABUS icon
172
Arbutus Biopharma
ABUS
$1.02B
$1.02B $5.15 0.59%
GERN icon
173
Geron
GERN
$1.01B
$1.01B $1.57 3.97%
LXRX icon
174
Lexicon Pharmaceuticals
LXRX
$997M
$997M $2.24 0.88%
IMMX icon
175
Immix Biopharma
IMMX
$990M
$990M $13.91 0.58%
5 6
7
8 9

Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 568 Biotechnology industry stocks tracked by Wall St. Rank, worth a combined $1.35T.

The largest by market cap are Vertex Pharmaceuticals (VRTX) at $138B, Regeneron Pharmaceuticals (REGN) at $85.2B and argenx (ARGX) at $64.6B.

Among institutional investors, Revolution Medicines (RVMD) drew the most net new fund positions in Q2 2026: 243 funds opened new positions, taking total fund holders up 177 (34%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.